Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 13 for:    ketamine bipolar disorder
Previous Study | Return to List | Next Study

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

This study has suspended participant recruitment.
Sponsor:
Information provided by (Responsible Party):
Juvenile Bipolar Research Foundation
ClinicalTrials.gov Identifier:
NCT01504659
First received: January 3, 2012
Last updated: November 20, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)